Spero Therapeutics

Spero Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel treatments for rare diseases and multidrug-resistant (MDR) bacterial infections. Their mission is to bring hope to patients and families suffering from these serious conditions, and they are committed to advancing new therapies in areas with high unmet medical needs. Spero's pipeline includes three investigational drug candidates: SPR720, an oral candidate for NTM pulmonary disease; Tebipenem HBr, an oral carbapenem for complicated urinary tract infections; and SPR206, an IV product candidate for treating MDR gram-negative infections.

Spero Therapeutics was founded in 2013 and is headquartered in Cambridge, Massachusetts. They have built strategic partnerships with government agencies, academic institutions, and pharmaceutical companies to advance their pipeline. Spero is dedicated to delivering differentiated medicines and believes that forming collaborations with external partners is essential to maximizing the reach and impact of their innovative therapies for patients.

Spero Therapeutics offers a flexible work environment, allowing employees to balance their professional and personal lives. The company recognizes the importance of work-life balance and provides the ability to work remotely or adjust schedules to accommodate individual needs. This commitment to flexibility fosters a positive and supportive work culture that attracts and retains top talent.

Spero Therapeutics offers a comprehensive and competitive benefits package, encompassing medical, dental, and vision insurance, as well as life and accidental death and dismemberment (AD&D) coverage. They provide short- and long-term disability insurance, a 401(k) plan with a company match, and a flexible work environment. These benefits contribute to a positive and supportive work environment where employees are valued and encouraged to learn and grow.

Spero Therapeutics is a clinical-stage biopharmaceutical company dedicated to delivering novel treatments for patients suffering from rare diseases and multidrug-resistant (MDR) bacterial infections. Their mission is to bring hope to patients and their families by developing innovative therapies that address significant unmet medical needs in these therapeutic areas. They are committed to advancing new approaches that can effectively and safely treat these challenging infections, potentially easing suffering and improving patient outcomes.

Spero Therapeutics promotes a culture that emphasizes collaboration, respect, and a commitment to excellence. The company fosters an inclusive and supportive work environment that values the contributions of all employees and encourages open communication. Spero prioritizes professional development and growth through various training programs and mentorship opportunities, creating a sense of camaraderie and shared purpose.

Spero Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace culture where all employees feel valued, respected, and empowered. The company believes that diversity of thought and background enhances innovation and creativity, leading to better outcomes for patients. Spero actively seeks individuals with unique talents who share their passion for delivering life-changing treatments for patients suffering from rare diseases and multidrug-resistant bacterial infections.